Inari Medical’s (NASDAQ:NARI) quiet period will expire on Wednesday, July 1st. Inari Medical had issued 8,202,565 shares in its initial public offering on May 22nd. The total size of the offering was $155,848,735 based on an initial share price of $19.00. During Inari Medical’s quiet period, insiders and underwriters involved in the IPO are restricted from issuing any research reports for the company because of SEC regulations. Following the end of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

A number of brokerages have recently issued reports on NARI. Canaccord Genuity began coverage on Inari Medical in a research note on Friday, June 19th. They set a “buy” rating and a $60.00 price objective on the stock. Bank of America began coverage on Inari Medical in a research note on Tuesday, June 16th. They set a “neutral” rating and a $56.00 price objective on the stock. Wells Fargo & Co began coverage on Inari Medical in a research note on Tuesday, June 16th. They set an “equal weight” rating and a $49.00 price objective on the stock. Finally, Morgan Stanley began coverage on Inari Medical in a research note on Tuesday, June 16th. They issued an “equal weight” rating and a $52.00 price target on the stock.

NARI opened at $48.02 on Wednesday. Inari Medical has a 1-year low of $39.55 and a 1-year high of $54.86.

In other Inari Medical news, major shareholder Presidio Management Group X. Ll purchased 97,962 shares of the company’s stock in a transaction that occurred on Wednesday, May 27th. The shares were acquired at an average price of $19.00 per share, for a total transaction of $1,861,278.00. Also, CEO William Hoffman purchased 13,095 shares of the company’s stock in a transaction that occurred on Wednesday, May 27th. The stock was acquired at an average price of $19.00 per share, for a total transaction of $248,805.00. In the last 90 days, insiders purchased 153,898 shares of company stock worth $2,924,062.

Inari Medical Company Profile

There is no company description available for Inari Medical Inc

See Also: What is required to own or exchange cryptocurrency?

Receive News & Ratings for Inari Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inari Medical and related companies with MarketBeat.com's FREE daily email newsletter.